A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Clinical Trial Grant
Awarded By
Vasa Therapeutics, Inc.
Start Date
March 31, 2026
End Date
December 3, 2035
Awarded By
Vasa Therapeutics, Inc.
Start Date
March 31, 2026
End Date
December 3, 2035